KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Labcorp Holdings' Non Operating Income fell 14418.6% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.2 million, marking a year-over-year decrease of 13096.77%. This contributed to the annual value of $60.2 million for FY2024, which is 28838.71% up from last year.
  • Labcorp Holdings' Non Operating Income amounted to -$1.9 million in Q3 2025, which was down 14418.6% from -$32.7 million recorded in Q2 2025.
  • Over the past 5 years, Labcorp Holdings' Non Operating Income peaked at $31.9 million during Q3 2021, and registered a low of -$36.0 million during Q4 2021.
  • Moreover, its 5-year median value for Non Operating Income was $4.3 million (2024), whereas its average is $1.5 million.
  • As far as peak fluctuations go, Labcorp Holdings' Non Operating Income tumbled by 30921.99% in 2022, and later soared by 38985.51% in 2024.
  • Labcorp Holdings' Non Operating Income (Quarter) stood at -$36.0 million in 2021, then skyrocketed by 185.0% to $30.6 million in 2022, then plummeted by 40.52% to $18.2 million in 2023, then decreased by 9.89% to $16.4 million in 2024, then tumbled by 111.59% to -$1.9 million in 2025.
  • Its Non Operating Income stands at -$1.9 million for Q3 2025, versus -$32.7 million for Q2 2025 and -$1.0 million for Q1 2025.